This article has Open Peer Review reports available.
A case of familial isolated hemihyperplasia
© Heilstedt and Bacino; licensee BioMed Central Ltd. 2004
Received: 18 November 2003
Accepted: 02 February 2004
Published: 02 February 2004
Hemihyperplasia (hemihypertrophy) is defined as asymmetric body overgrowth of one or more body parts. Hemihyperplasia can be isolated or be part of well-defined syndromes such as in the case of Beckwith-Wiedemann syndrome (BWS). Isolated hemihyperplasia is usually sporadic, but a number of familial occurrences have been described.
We describe a Tunisian family in which three maternal cousins and their maternal grandfather present with isolated hemihyperplasia.
The etiology of isolated hemihyperplasia is unknown although in BWS, genomic imprinting has been shown to play a role in the asymmetric overgrowth. Given the similarity between these two conditions, it is possible that both may share a common pathogenesis. We also discuss the possible genetic mechanisms leading to the production of hemihyperplasia in this family.
Hemihyperplasia, formerly referred to as hemihypertrophy, is an asymmetric overgrowth involving one or more body parts [1–3]. Hemihyperplasia can be isolated or can occur as part of a syndrome. There have been several syndromes in which hemihyperplasia has been described, these include: Beckwith-Wiedemann syndrome (BWS), Proteus syndrome, Russell-Silver syndrome, Neurofibromatosis type I (NF I) and Klippel-Trénaunay-Weber syndrome (KTW) [2, 3]. All of these conditions have well characterized features in addition to the hemihyperplasia. Isolated hemihyperplasia therefore must be differentiated from overgrowth that is part of a clinically recognized syndrome, since there are many prognostic implications for those individuals with an underlying syndromic diagnosis.
The prevalence of isolated hemihyperplasia is difficult to establish accurately, because many cases may be so mild as not to come to medical attention. The prevalence of hemihyperplasia has been estimated to be 1 in 13,200 live births . This figure, however, may not be the most accurate since both isolated and syndromic forms of hemihyperplasia were included. Another large study  looked at 860,000 inpatient records and found a total of 10 cases with congenital asymmetry, suggesting that the prevalence for hemihyperplasia is approximately 1 in 86,000. However, several of the patients included in this survey had other congenital abnormalities, including BWS. Lastly, a study done in 1980 surveyed 14,430 consecutive live born infants delivered in a large maternity hospital in Tokyo and found only one newborn with hemihyperplasia . These are the only epidemiological studies on hemihyperplasia published in the literature, and given their limitations; it is difficult to estimate the real prevalence of this disorder in the general population.
When a clinician is faced with the evaluation of a patient with hemihyperplasia, it is very important to differentiate the isolated forms of hemihyperplasia from the syndromic ones, since the morbidity risks and follow up approaches could be significantly different. For example, Proteus syndrome, KTW and BWS carry different risks and have very different clinical management issues in comparison to isolated hemihyperplasia. All of these entities are usually sporadic cases and have a low recurrence risk. However, there have been several familial cases of BWS reported in the literature . Isolated hemihyperplasia (likewise BWS) is usually sporadic with a low recurrence risk, however, there have been several reports of familial hemihyperplasia described in the literature with two or more affected relatives [8–16]. In this manuscript we describe a Tunisian family with several individuals affected with isolated hemihyperplasia. In addition, we have conducted a review of the literature specifically involving familial occurrences to evaluate the modes of inheritance that have been described previously, and comment on the possible molecular mechanisms leading to the occurrence of hemihyperplasia in this family.
The propositus in this family (Patient 1, III:1) is a 2 year-old Tunisian male who was diagnosed with right-sided hemihyperplasia. He was being followed by periodic abdominal ultrasounds every six months to screen for abdominal tumors. One month prior to our examination of the patient, three nodules were noted on his kidney by ultrasonography. Further evaluation revealed he had unilateral Wilms tumor with a negative metastatic work-up. The patient underwent tumor resection followed by chemotherapy with good outcome. His medical history was significant for the diagnosis of hemihyperplasia a few months after birth. He had no other medical problems until the development of the Wilms tumor. His birth weight was 3.6 kg (75th centile). His development has been normal for age. His physical examination at 2 years of age revealed: weight 20.9 kg (>95th centile), height 97 cm (>95th centile) and head circumference 55 cm (>95th centile). His clinical exam revealed hemihyperplasia involving both his right upper and right lower extremities. He had a leg-length discrepancy with his right leg being 3 cm longer than the left measured on clinical examination. His right calf circumference was 26 cm while his left calf circumference was 23 cm. He had no dysmorphic features or other abnormal findings on his physical examination. The neurological exam was normal. Specifically, he had no macroglossia, history of abdominal wall defects, ear lobe creases, café-au-lait macules or vascular abnormalities. G-band chromosome analysis performed on peripheral blood lymphocytes at approximately 550-band resolution level was reported as normal. No cytogenetic abnormalities were detected in the 11p15 region.
We have identified a family with four individuals affected with isolated hemihyperplasia. We have examined two members of the family while the two other are not available for direct physical examination. The transmission of the hemihyperplasia in this family could be compatible with autosomal dominant inheritance with incomplete penetrance, but given what we know about BWS, we propose that the hemihyperplasia in this family could also be the result of an imprinting defect. Of the familial cases of hemihyperplasia in the literature, seven had direct parent to child transmission [9, 11, 12, 14–16]. However, in many of these families additional findings were also reported. Scott  described a family in which the mother and daughter were affected with hemihyperplasia but, in addition, the daughter had congenital heart disease and nevi. Morris and MacGillivray  also described a family in which both the mother and daughter were affected with hemihyperplasia but both individuals had mental retardation in addition as well as a psychiatric disorder. The mother was noted to have pigmented lesions while the daughter had pes cavus. Slavotinek et al.  reported a mother and son with apparent isolated hemihypertrophy. The presentation was unusual, however, in that the chest asymmetry in the son and the leg length discrepancy in the mother were not noted until adolescence. Stoll et al.  reported a mother and daughter with hemihyperlasia and in addition the daughter was noted to have an extra nipple. There have been three families reported with parent to child transmission of hemihyperplasia involving the face only. Rudolph and Norvold  reported a child, mother and grandmother each with facial asymmetry. Bencze et al.  described a three-generation family with apparent autosomal dominant transmission of facial hemihyperplasia and strabismus. Burchfield and Escobar  reported a family with father to son transmission of facial asymmetry and severe malocclusion. Several other family members were also affected. The family described by Burchfield and Escobar is unique in that it is the only family described with known male-to-male transmission, in all other families the affected individuals were related through the maternal lineage.
In addition to the families described with parent to child transmission, there have been three reports of siblings with hemihyperplasia. One case reported two sisters with complete left-sided hemihyperplasia, however they additionally had significant mental retardation . In this family, their maternal grandmother apparently had left facial hemihyperplasia but did not have mental retardation therefore it is unclear if the retardation was an unrelated finding. One other reported family showed a brother and sister with complete right-sided hemihyperplasia . The brother had a history of seizures and the sister had mental retardation, nevi and strabismus. Fraumeni et al. reported a family in which a female presented with right-sided hemihyperplasia of the arm, leg and tongue as well as a Wilms tumor of the left kidney . Her brother had right-sided hemihyperplasia of the leg. Furthermore, a maternal uncle was reported as having his right leg longer than his left leg. Lastly, Arnold  reported a nephew and uncle with possible hemihyperplasia. The male child had right-sided hemiacromegaly with early eruption of several permanent teeth and his maternal uncle was also said to have an "enlarged right cheek", the authors state that he was not evaluated clinically.
These reported families do not point to a clear inheritance pattern of transmission in hemihyperplasia. In all but one reported family , the transmission of hemihyperplasia occurred through maternal relatives. It must be noted though that in several cases there were other abnormalities present besides the body asymmetry, suggesting that these families may not truly qualify for isolated hemihyperplasia. In the family we present, there are clearly two maternal cousins with isolated hemihyperplasia presenting in infancy. One cousin developed Wilms tumor. Both individuals were examined and clearly did not fit diagnostic criteria for any syndromic form of hemihyperplasia.
It has been suggested that isolated hemihyperplasia may be part of the BWS spectrum . BWS is a syndrome of pre and post-natal overgrowth, macroglossia, omphalocele, neonatal hypoglycemia and hemihyperplasia. The etiology of BWS is complex and thought to be the result of a genomic imprinting defect [7, 18, 19]. Genomic imprinting refers to an epigenetic phenomenon characterized by monoallelic expression of a gene depending on its parent of origin . The mechanisms leading to imprinting are complex and consist of a parental specific mark or imprint that is established in gametogenesis. This imprint mark must be switchable when transmission occurs through members of the opposite sex, for example from a mother to her son. Although the exact molecular mechanisms for BWS still remain elusive, several genetic mechanisms have been postulated as probable cause [19, 21, 22]. BWS appears to be associated with abnormal expression of a gene/s on chromosome 11p15, which is one of the few imprinted regions of the human genome. The paternally expressed genes on 11p15 include: Insulin Growth Factor 2 (IGF2) that is a growth promoter, and KCNQ1-overlapping transcript 1 (KCNQ1OT1 or LIT1). Some of the maternally expressed genes include cyclin-dependent kinase inhibitor 1C (CDKN1C) a cell cycle inhibitor also known as p57(KIP2); KCNQ1, a potassium channel, voltage-gated gene also known as KvLQT1, and H19 that codes for an untranslated RNA . The region is further divided into two distinct domains. Domain 1 contains IGF2 and H19, and Domain 2 contains CDKN1C, KCNQ1OT1, and KCNQ1. In addition, these two domains are apparently regulated by two distinct imprinting centers. The imprinting centers are thought to maintain the imprints in somatic cells but also play a role in resetting the imprint in the germline . The genetic lesions described thus far in BWS include paternal duplications of 11p15, maternal translocations that disrupt the 11p15 region and mutations of CDKN1C. However, the majority of BWS cases have no identifiable genetic alteration. It is believed that most cases of BWS are caused by epigenetic factors. One such situation is paternal uniparental disomy of 11p15 that occurs in 10–20% of BWS cases . Even though the genetic and epigenetic mechanisms involved in BWS are quite complex and not fully understood, it is widely accepted that BWS results from dysregulation of several closely linked genes on 11p15 which are involved in cell cycle regulation and growth control. Further supportive evidence can be surmised from evaluation of maternal duplications of 11p15. Recently, Fisher et al.  reported the first three cases of maternal duplications of the BWS region. The phenotype in these three patients included growth retardation, in contrast to the characteristic overgrowth seen in paternal duplications of this region (BWS). Another study looked at epigenetic alterations of H19 and LIT1 in BWS patients . In this particular cohort of patients, 92 children with BWS were studied molecularly showing some interesting results. 39 out of the 92 children studied (42%) had an altered methylation pattern of LIT1 with normal H19 methylation, 10 out the 92 (11%) had an abnormal methylation pattern of H19 with normal LIT1, and 12 out of the 92 (13%) had altered methylation on both H19 and LIT1. From this last group, only 9 have paternal UPD, which was somehow expected, but the remaining 3 had biparental inheritance for the 11p15 region. This result strongly suggests the role of epigenetic mutations in BWS. Interestingly, in this group with abnormal methylation for both H19 and LIT1, as well as in those cases with paternal UPD for the 11p15 region, there was a higher incidence for hemihyperplasia. The association of UPD and hemihyperplasia in BWS has also been supported but previous clinical-molecular studies.
Although BWS usually is sporadic, there have been several families described with autosomal dominant inheritance. CDKN1C mutations account for a larger portion of familial cases of BWS than sporadic cases, but the mechanism for the majority of cases is still unknown. Viljoen et al.  described a family with BWS, and reviewed 27 kindred's with familial BWS reported thus far in the literature and in all but four cases; the inheritance pattern was potentially consistent with an imprinting defect.
The transmission pattern of hemihyperplasia in the family presented here could also be consistent with a similar imprinting mechanism. The maternal grandfather (I-1) of the two male cousins discussed here (III-1 and III-3), is reported to have hemihyperplasia. If we assume that I-1 has an imprinting abnormality (such that of IGF2 itself or of it's imprinting center) of his maternally derived allele that allows over expression of a growth-promoting factor such as IGF2, this could lead to hemihyperplasia. His maternal allele should normally be silent and now is active secondary to an epigenetic defect. This individual will also have his paternal copy that would result in functional duplication and over expression of the IGF2 genes. If this mutated allele was then transmitted from the grandfather to his daughters (II2, II6 and II9), it would behave normally, since a paternal allele would normally express IGF2. These individuals would not be affected but would be potential carriers. They have now the paternal "active" allele and the maternally silent allele. These individuals would then have a 50% chance of passing this abnormally imprinted allele to their offspring. During gametogenesis in individuals II2, II6 and II9 the imprinting mark on this allele should be changed to a maternal, "silent" pattern. However, if a particular epigenetic change renders this allele unable to be reverted back to its silent form, it will continue to have a paternal pattern of expression. In this case the offspring that inherit this allele will now have a net gain overexpression of a growth promoter such as IGF2 therefore leading in this case to hemihyperplasia. Certainly, loss of IGF2 imprinting is not the only possibility in this family, as the molecular mechanisms and interactions of the imprinted genes on 11p15 are quite complex, but the molecular mechanism (abnormal imprinting) proposed in this family, could be consistent with the paternal imprint model as proposed for familial BWS. The other families reported in the literature with hemihyperplasia showing autosomal dominant inheritance and maternal transmission could also be consistent with an imprinting mutation as well, (although they could be more consistent with a maternal imprint) [9, 11, 12, 15]. Cytogenetic analysis was performed in three of these families  ruling out the possibility of maternal translocations, however, this cannot be completely ruled out in the other families. Moreover, it is unclear whether some of the other families reported in the literature can be considered as isolated hemihyperplasia as there are other abnormalities found in these individuals. Not all the reported families however would fit with an imprinting pattern of inheritance , but as the majority cases for BWS and hemihyperplasia remains unknown, these families could represent different molecular mechanisms caused by disturbance of balance between growth promoters and suppressors. Similarly, the reported families with isolated facial hemihyperplasia [14, 16] do not fit with an imprinting pattern of inheritance. In summary, hemihyperplasia and similarly to what is seen BWS, is a heterogenoeus group of disorders possibly caused by different molecular mechanisms. In the family presented in this paper is certainly interesting to hypothesize a paternal imprint defect. This additional family also raises caution when counseling is done to these individuals. A good family history with particular attention to overgrowth is warranted in these patients. We believe that clinicians should continue quoting a low recurrence risk for hemihyperplasia, however, the rare possibility of familial recurrences needs to be reported in our opinion as part of the routine counseling.
We have been unable to obtain written consent for this publication since the family presented here was unfortunately lost to follow up.
- Bueno I, Ventura P, Samper MP, Perez Gonzalez JM, Bueno M: Congenital hemihypertrophy. Genet Couns. 1993, 4 (3): 231-4.PubMedGoogle Scholar
- Ballock RT, Wiesner GL, Myers MT, Thompson GH: Hemihypertrophy. Concepts and controversies. J Bone Joint Surg Am. 1997, 79 (11): 1731-8.PubMedGoogle Scholar
- Hoyme HE, Seaver LH, Jones KL, Procopio F, Crooks W, Feingold M: Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet. 1998, 79 (4): 274-8. 10.1002/(SICI)1096-8628(19981002)79:4<274::AID-AJMG8>3.3.CO;2-K.View ArticlePubMedGoogle Scholar
- Leck I, Record RG, McKeown T, Edwards JH: The incidence of malformations in Birmingham, England, 1950–1959. Teratology. 1968, 1 (3): 263-80.View ArticlePubMedGoogle Scholar
- Parker DASkalko RG: Congenital asymmetry: report of 10 cases with associated developmental abnormalities. Pediatrics. 1969, 44 (4): 584-9.Google Scholar
- Higurashi M, Iijima K, Sugimoto Y, Ishikawa N, Hoshina H, Watanabe N, Yoneyama K: The birth prevalence of malformation syndromes in Tokyo infants: a survey of 14,430 newborn infants. Am J Med Genet. 1980, 6 (3): 189-94.View ArticlePubMedGoogle Scholar
- Viljoen D, Ramesar R: Evidence for paternal imprinting in familial Beckwith-Wiedemann syndrome. J Med Genet. 1992, 29 (4): 221-5.View ArticlePubMedPubMed CentralGoogle Scholar
- Reed EA: Congenital Total Hemihypertrophy. Archives of Neurology and Psychiatry. 1925, 14: 824-827.View ArticleGoogle Scholar
- Scott AJ: Hemihypertrophy. Report of Four Cases. J Pediatr. 1935, 6: 650-656.View ArticleGoogle Scholar
- Arnold EB: Case of Hemiacromegaly Showing Eruption of Maxillary Right Permanent Canine and Mandibular Right First Premolar at Four and One-Half Years of Age. 1936, 22: 1228-1233.Google Scholar
- Rudolph CE, Norvold RW: Congenital Partial Hemihypertrophy Involving Marked Maloclusion. J Dent Res. 1944, 23: 133-139.View ArticleGoogle Scholar
- Morris JV, MacGillivray RC: Mental Defect and Hemihypertrophy. Am J Ment Defic. 1955, 59: 645-650.PubMedGoogle Scholar
- Fraumeni JF, Geiser CF, Manning MD: Wilms' tumor and congenital hemihypertrophy: report of five new cases and review of literature. Pediatrics. 1967, 40 (5): 886-99.PubMedGoogle Scholar
- Burchfield D, Escobar V: Familial facial asymmetry (autosomal dominant hemihypertrophy?). Oral Surg Oral Med Oral Pathol. 1980, 50 (4): 321-4.View ArticlePubMedGoogle Scholar
- Stoll C, Alembik Y, Steib JP, De Saint-Martin A: Twelve cases with hemihypertrophy: Etiology and follow up. Genet Couns. 1993, 4 (2): 119-26.PubMedGoogle Scholar
- Bencze J, Schnitzler A, Walawska J: Dominant inheritance of hemifacial hyperplasia associated with strabismus. Oral Surg Oral Med Oral Pathol. 1973, 35 (4): 489-500.View ArticlePubMedGoogle Scholar
- Slavotinek AM, Collins MT, Muenke M: Non-syndromic hemihyperplasia in a male and his mother. Am J Med Genet. 2003, 121A (1): 47-51. 10.1002/ajmg.a.10177.View ArticlePubMedGoogle Scholar
- Weksberg R, Teshima I, Williams BR, Greenberg CR, Pueschel SM, Chernos JE, Fowlow SB, Hoyme E, Anderson IJ, Whiteman DA: Molecular characterization of cytogenetic alterations associated with the Beckwith-Wiedemann syndrome (BWS) phenotype refines the localization and suggests the gene for BWS is imprinted. Hum Mol Genet. 1993, 5 (2): 549-56.View ArticleGoogle Scholar
- Weksberg R, Squire JA: Molecular biology of Beckwith-Wiedemann syndrome. Med Pediatr Oncol. 1996, 27 (5): 462-9. 10.1002/(SICI)1096-911X(199611)27:5<462::AID-MPO13>3.0.CO;2-C.View ArticlePubMedGoogle Scholar
- Mannens M, Alders M: Genomic imprinting: concept and clinical consequences. Ann Med. 1999, 31 (1): 4-11.View ArticlePubMedGoogle Scholar
- Li M, Squire JA, Weksberg R: Overgrowth syndromes and genomic imprinting: from mouse to man. Clin Genet. 1998, 53 (3): 165-70.View ArticlePubMedGoogle Scholar
- Li M, Squire JA, Weksberg R: Molecular genetics of Beckwith-Wiedemann syndrome. Curr Opin Pediatr. 1997, 6 (9): 623-9.View ArticleGoogle Scholar
- Weksberg R, Smith AC, Squire J, Sadowski P: Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet. 2003, 12 Spec No 1: R61-8. 10.1093/hmg/ddg067.View ArticlePubMedGoogle Scholar
- Fisher AM, Thomas NS, Cockwell A, Stecko O, Kerr B, Temple IK, Clayton P: Duplications of chromosome 11p15 of maternal origin result in a phenotype that includes growth retardation. Hum Genet. 2002, 111 (3): 290-6. 10.1007/s00439-002-0787-2.View ArticlePubMedGoogle Scholar
- DeBaun MR, Niemitz EL, McNeil DE, Brandenburg SA, Lee MP, Feinberg AP: Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects. Am J Hum Genet. 2002, 70 (3): 604-11. 10.1086/338934.View ArticlePubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2350/5/1/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.